# Hypertrophic Scar Prevention by Novel Topical Gel Application

> **NCT03403621** · PHASE1,PHASE2 · TERMINATED · sponsor: **Mayo Clinic** · enrollment: 6 (actual)

## Conditions studied

- Hypertrophic Scar

## Interventions

- **DRUG:** Pentamidine Isethionate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03403621
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-03-05
- **Primary completion:** 2020-02-26
- **Final completion:** 2020-02-26
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Funding changes.
- **Last updated:** 2023-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03403621

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03403621, "Hypertrophic Scar Prevention by Novel Topical Gel Application". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03403621. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*